Ann: Strategy for Phase II Clinical Trial of Monepantel, page-3

I have to confess that the two things that have really tested my patience with the company is the poor, almost non-existent PR (RedChip is changing that, even if its style is debatable) and the looooooooong waits. I would have expected that after the excellent phase 1 results in October, we would have been into phase II by this month with the reformulated tablets. Oh well, another way to see it is that at least we now know roughly when they'll start, that they'll be done in 3 countries, and it's only 2 months to go and I picked up some really cheap shares on the way.